标题
Immunotoxin: A new tool for cancer therapy
作者
关键词
-
出版物
TUMOR BIOLOGY
Volume 39, Issue 2, Pages 101042831769222
出版商
SAGE Publications
发表日期
2017-02-20
DOI
10.1177/1010428317692226
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Advances in Anticancer Immunotoxin Therapy
- (2015) C. Alewine et al. ONCOLOGIST
- Immunotoxins for leukemia
- (2014) A. S. Wayne et al. BLOOD
- GM-CSF-DFF40: a novel humanized immunotoxin induces apoptosis in acute myeloid leukemia cells
- (2013) Mrudula Mathew et al. APOPTOSIS
- Antitumor Activity of a Humanized, Bivalent Immunotoxin Targeting Fn14-Positive Solid Tumors
- (2013) H. Zhou et al. CANCER RESEARCH
- The Insulin Receptor Negatively Regulates the Action of Pseudomonas Toxin-Based Immunotoxins and Native Pseudomonas Toxin
- (2013) X. F. Liu et al. CANCER RESEARCH
- Abrin Immunotoxin: Targeted Cytotoxicity and Intracellular Trafficking Pathway
- (2013) Sudarshan Gadadhar et al. PLoS One
- Immunotoxins: The Role of the Toxin
- (2013) Antonella Antignani et al. Toxins
- Therapeutic targets and recent advances in protein immunotoxins
- (2012) Madhumathi J et al. CURRENT OPINION IN MICROBIOLOGY
- Combination treatments with ABT-263 and an immunotoxin produce synergistic killing of ABT-263-resistant small cell lung cancer cell lines
- (2012) Abid R. Mattoo et al. INTERNATIONAL JOURNAL OF CANCER
- Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes
- (2012) W. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategy
- (2012) H. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia
- (2011) John Schindler et al. BRITISH JOURNAL OF HAEMATOLOGY
- Treatment of Hematologic Malignancies with Immunotoxins and Antibody-Drug Conjugates
- (2011) D. J. FitzGerald et al. CANCER RESEARCH
- Therapeutic potential of anticancer immunotoxins
- (2011) Swati Choudhary et al. DRUG DISCOVERY TODAY
- Design of Targeted B Cell Killing Agents
- (2011) Alexey V. Stepanov et al. PLoS One
- Recombinant immunotoxin against B-cell malignancies with no immunogenicity in mice by removal of B-cell epitopes
- (2011) M. Onda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Research and development of next generation of antibody-based therapeutics
- (2010) Jing Li et al. ACTA PHARMACOLOGICA SINICA
- Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study
- (2010) B. Lowenberg et al. BLOOD
- Intracellular Activation of SGN-35, a Potent Anti-CD30 Antibody-Drug Conjugate
- (2010) N. M. Okeley et al. CLINICAL CANCER RESEARCH
- Phase III Placebo-Controlled Trial of Denileukin Diftitox for Patients With Cutaneous T-Cell Lymphoma
- (2010) H. Miles Prince et al. JOURNAL OF CLINICAL ONCOLOGY
- Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
- (2010) Anas Younes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recombinant Immunotoxins Containing Truncated Bacterial Toxins for the Treatment of Hematologic Malignancies
- (2009) Robert J. Kreitman BIODRUGS
- Characterization of variant diphtheria toxin–interleukin-3 fusion protein, DTIL3K116W, for phase I clinical trials
- (2009) Yunpeng Su et al. BIOLOGICALS
- Humanized immunotoxins: A new generation of immunotoxins for targeted cancer therapy
- (2009) Mrudula Mathew et al. CANCER SCIENCE
- A Phase 1 Study of Combotox in Pediatric Patients With Refractory B-lineage Acute Lymphoblastic Leukemia
- (2009) Larry Herrera et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Whatever Happened to Immunotoxins? Research, and Hope, Are Still Alive
- (2009) D. C. Holzman JNCI-Journal of the National Cancer Institute
- Cancer incidence and mortality in Iran
- (2008) S. M. Mousavi et al. ANNALS OF ONCOLOGY
- Differential Cellular Internalization of Anti-CD19 and -CD22 Immunotoxins Results in Different Cytotoxic Activity
- (2008) X. Du et al. CANCER RESEARCH
- Monoclonal Antibodies as Innovative Therapeutics
- (2008) Janice Reichert CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Safety and Efficacy of Gemtuzumab Ozogamicin in Combination With Chemotherapy for Pediatric Acute Myeloid Leukemia: A Report From The Children's Oncology Group
- (2008) Richard Aplenc et al. JOURNAL OF CLINICAL ONCOLOGY
- An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes
- (2008) M. Onda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started